NASDAQ:GERN

Geron Stock Predictions

Healthcare > Biotechnology

Buy GERN

*Your capital is at risk

$1.16

-0.0100 (-0.85%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

GERN Prediction Chart

GERN Predictions History

Latest community submissions for GERN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Joseph.Booher.22470	Mar 23, 2018	$2.03 -64.01%	$5.64	X	36.00%	0
JS Pro	Jan 31, 2018	$2.48 +1.22%	$2.45	X	98.80%	1
Metallica @Metallica.18524	Jan 31, 2018	$2.32 -5.31%	$2.45	X	94.70%	0
Mohammad.Hamzeh.1653	Dec 2, 2016	$2.00 -0.50%	$2.01	X	99.50%	4
Mohammad.Hamzeh.1653	Nov 30, 2016	$2.19 +7.35%	$2.04	X	92.60%	0
StockVader Merchant	Sep 21, 2016	$2.12 -5.78%	$2.25	X	94.20%	0
PumpTheseNumbers Pro	Sep 21, 2016	$2.18 -3.11%	$2.25	X	96.90%	0
JS Pro	Sep 21, 2016	$2.11 -6.22%	$2.25	X	93.80%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GERN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT GERON CORPORATION

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by